Results 61 to 70 of about 4,911,045 (202)

A Case of Tardive Akathisia and Dyskinesia [PDF]

Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2007
Various drugs, mainly antipsychotics in psychiatry may induce movement disorders. These acute or tardive type movement disorders could either be in hypokinetic or in hyperkinetic form. There are other movement disorders in tardive type (e.g.
Timuçin Oral, Erhan Kurt, Aslı Kalkay, Oya Öztürk, Feriha Özer   +4 more
doaj  

Sertraline induced mandibular dystonia and bruxism

Journal of Family Medicine and Primary Care, 2016
Specific serotonin reuptake inhibitors have been associated with the occurrence of drug-induced parkinsonism, dystonia, dyskinesia, and akathisia. Here, we describe a young female patient with a diagnosis of the moderate depressive episode who developed ...
N A Uvais, V S Sreeraj, S V Sathish Kumar   +2 more
doaj   +1 more source

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia

Clinical Pharmacology: Advances and Applications, 2020
Assefa Kumsa, Shimelis Girma, Bezaye Alemu, Liyew Agenagnew Department of Psychiatry, Faculty of Medical Science, Institute of Health, Jimma University, Jimma, EthiopiaCorrespondence: Liyew AgenagnewJimma University, 378, Jimma, EthiopiaTel +251 ...
Kumsa A, Girma S, Alemu B, Agenagnew L
doaj  

Trends in overdose and other drug-induced deaths in Australia, 2004-2023 [PDF]

The National Illicit Drug Indicators Project provides epidemiological data on trends over time in drug-related harms and forms part of the broader Drug Trends program.
Chrzanowska, Agata ; https://orcid.org/, Degenhardt, Louisa, Sutherland, Rachel ; https://orcid.org/, Man, Nicola, Peacock, Amy   +4 more
core   +1 more source

Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease

Parkinson's Disease, 2012
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal involuntary movements, limiting its use in advanced stages of the disease.
Eunju Shin, Elisabetta Tronci, Manolo Carta   +2 more
doaj   +1 more source

Dyskinesia induced by phenytoin Discinesia induzida por fenitoína

Arquivos de Neuro-Psiquiatria, 1999
Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. OBJECTIVE: To describe the clinical characteristics of phenytoin induced dyskinesia.
M. AUGUSTA MONTENEGRO, ANNA ELISA SCOTONI, FERNANDO CENDES   +2 more
doaj   +1 more source

Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia

, 2018
Background: Tardive dyskinesia (TD) is a disabling movement disorder associated with the prolonged use of antipsychotic medication. Several strategies have been examined in the treatment of TD.
Rathbone, John, Hanna Bergman, Karla Soares-Weiser, Bergman, Hanna, El-Sayeh, Hany G., Hany G El-Sayeh, El-Sayeh, Hany G, John Rathbone, Soares-Weiser, Karla   +8 more
core   +1 more source

Canine paroxysmal dyskinesia—a review

Frontiers in Veterinary Science
Paroxysmal dyskinesias (PDs) are a group of involuntary, hyperkinetic movement disorders that recur episodically and may last seconds to hours. An important feature of PD is that there is no loss of consciousness during the episode.
Paul J. J. Mandigers, Paul J. J. Mandigers, Koen M. Santifort, Koen M. Santifort, Koen M. Santifort, Mark Lowrie, Laurent Garosi   +6 more
doaj   +1 more source

Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia. [PDF]

, 2006
L-3,4-dihydroxyphenylalanine (L-DOPA) remains the most efficacious drug for the treatment of Parkinson's disease (PD), but causes adverse effects that limit its utility. L-DOPA-induced dyskinesia (abnormal involuntary movements) is a significant clinical
Martin Lundblad, Lundblad, Martin, Cenci Nilsson, Angela, M. Angela Cenci   +3 more
core   +1 more source

Ziconotide-Induced Oro-lingual Dyskinesia: 3 Cases.

, 2020
BACKGROUND: Ziconotide (ZCN), a nonopioid analgesic, is first-line intrathecal therapy for patients with severe chronic pain refractory to other management options. We describe three cases of ZCN-induced movement disorders.
Azher, Sharmeen, Gupta, Megan, Grajny, Kristopher, MD, Adam, Octavian, Durphy, Jennifer, Molho, Eric   +5 more
core   +1 more source